Kae Capital, an early-stage investment firm, has successfully closed its Winners Fund II (KWF II) by raising $50 million (Rs 410 crores) for investments in its portfolio startups. The fund garnered significant interest, just like its previous funds. Prominent participants in the fund include Velo Partners, Henry Kravis (co-founder and co-executive Chairman of KKR), 360 ONE (formerly IIFL Wealth and Asset Management), Prashant Tandon and Tanmay Saksena (Co-founder/CEO & COO, Tata 1MG), Sameer Maheshwari (Founder, HealthKart), Abhay Soi (Founder of Max Healthcare), Hemendra Kothari (Founder, DSP Group), Yogesh Agrawal (MD, Ajanta Pharma), Sanket and Apurva Parekh (Pidilite), and VM Thapar Family Office.

With a history of investing in India spanning over a decade, Kae Capital has already invested in 81 startups, amassing a portfolio enterprise valuation of $8.76 billion and achieving 14 successful exits. Through KWF II, Kae Capital aims to invest in 20 companies, primarily focusing on initial cheque sizes ranging between $1-3 million. Notably, Kae Capital has been an early-stage investor in several leading companies, including Porter, Zetwerk, HealthKart, Nazara, and Tata 1MG.

Speaking on the fundraiser, Sasha Mirchandani, partner of Kae Capital, said, We are delighted to announce the closure of Kae Winners Fund II. Being pioneers of early-stage investing in India, we’ve seen the ecosystem grow and see enough merit in being involved for as long as possible in a company’s lifecycle. We have launched this fund to continue backing our best founders, alongside other successful founders in the ecosystem, who are not yet a part of the Kae family.